Exparel Injection, Suspension, Liposomal
Product Images NDC 65250-133

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Exparel (NDC 65250-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pacira Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Exparel 01)

Chemical structure of bupivacaine, the active ingredient in EXPAREL. The diagram shows the molecular configuration including a piperidine ring attached to an amide linkage and a substituted aromatic ring with two methyl groups.*

FDA Label Image

Figure 1 (Exparel 02)

A line graph comparing placebo and EXPAREL (bupivacaine liposomal injection) over time up to 72 hours. The y-axis represents PI values, and the x-axis represents time in hours. Two lines with error bars show the changes in PI for placebo and EXPAREL groups, with the placebo group showing higher initial PI values that decrease over time more steeply than EXPAREL.*

FDA Label Image

10 mL Vial Label (Exparel 03)

EXPAREL 1.3% (bupivacaine liposome injectable suspension) injection label for infiltration and interscalene brachial plexus nerve block. The sterile 10 mL vial contains 133 mg per 10 mL (13.3 mg/mL). Manufactured for Pacira Pharmaceuticals, Inc., the label instructs to protect from freezing and refrigerate at 2° to 8°C, with disposal of any unused portion.*

FDA Label Image

10 mL 10-count Carton Label (Exparel 04)

EXPAREL 1.3% bupivacaine liposome injectable suspension carton label, showing 133 mg/10 mL (13.3 mg/mL) strength. The label states its use for infiltration and interscalene brachial plexus nerve block, with storage instructions and warnings. It contains 10 vials of 10 mL each. Manufactured by Pacira Pharmaceuticals, Inc.*

FDA Label Image

10 mL 4-count Carton Label (Exparel 05)

EXPAREL 1.3% (bupivacaine liposome injectable suspension) 133 mg/10 mL (13.3 mg/mL) injection, suspension, liposomal, for infiltration and interscalene brachial plexus nerve block. The label shows a carton containing 4 vials of 10 mL each. Manufactured by Pacira Pharmaceuticals, Inc., Parsippany, NJ. Storage instructions advise protection from freezing and refrigeration at 2°C to 8°C (36°F to 46°F).*

FDA Label Image

20 mL Vial Label (Exparel 06)

Label for EXPAREL (bupivacaine liposome injectable suspension) 1.3% injection, suspension, liposomal, with 266 mg/20 mL (13.3 mg/mL) strength. The label indicates it is for infiltration and interscalene brachial plexus nerve block only, not for other routes. It is a single-dose 20 mL vial, Rx only, manufactured by Pacira Pharmaceuticals, Inc. Storage instructions and barcode are also visible.*

FDA Label Image

20 mL 10-count Carton Label (Exparel 07)

EXPAREL 1.3% (bupivacaine liposome injectable suspension) injection, suspension, liposomal, 13.3 mg/mL strength, packaged in 20 mL vials, with 10 vials per carton. Label includes usage for infiltration and interscalene brachial plexus nerve block, storage instructions, and manufacturer Pacira Pharmaceuticals, Inc. Located at 5 Sylvan Way Parsippany, NJ.*

FDA Label Image

20 mL 4-count Carton Label (Exparel 08)

Packaging label for EXPAREL 1.3% (bupivacaine liposome injectable suspension) at 13.3 mg/mL strength. The label indicates a 20 mL vial containing 266 mg of bupivacaine. It is labeled for infiltration and interscalene brachial plexus nerve block, distributed by Pacira Pharmaceuticals, Inc. The label includes storage instructions, drug concentration, NDC number 65250-266-04, and a note that the product is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.